FREE Daily Stock Alerts From Stock-PR.com
Power3 Medical Products, Inc. (OTC:PWRM)
Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroProÂ®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials.
These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
The NuroPro Blood Test is Power3's medical diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).
Lou Gehrig's disease refers to a disorder called amyotrophic lateral sclerosis (ALS). Lou Gehrig's disease damages spinal cord pathways and motor neurons, which are important parts of the body's neuromuscular system. The neuromuscular system enables our bodies to move and is made up of the brain, nerves, and muscles. Things that we do every day, like breathing, walking, running, and over all moving, are all controlled by the neuromuscular system. Over time, Lou Gehrig's disease causes these motor neurons in the brain and spinal cord to shrink and disappear, so that the muscles no longer receive signals to move. As a result, the muscles become smaller and weaker. The body then becomes partially paralyzed.
Please visit Power3 Medical Products, Inc website http://www.power3medical.com.
WPP plc (Nasdaq:WPPGY) the global communications services group, was recognized at the weekend as Holding Company of the Year by judges at the 2011 Cannes Lions International Festival of Creativity, the world's premier showcase for excellence in communications. This marks the first time the Cannes Lions have measured and recognised creative performance at the parent company level. Based on the collective number of Cannes Lions awarded to WPP agencies for creative excellence, WPP accumulated 1,219 points in the competition, followed by Omnicom second with 1,152 points and Publicis with 744 points.
WPP plc, together with its subsidiaries, offers various communications services worldwide. It provides global, national, and specialist advertising services; above- and below-the-line media planning, buying, and specialist sponsorship and branded entertainment services; and specializes in brand, consumer, media, and marketplace insight, as well as works with clients to generate and apply insights.
IberiaBank Corp. (NASDAQ:IBKC) announced the declaration of a quarterly cash dividend of $0.34 per share. The dividend is payable on July 29, 2011, to shareholders of record as of June 30, 2011. This dividend level equates to an annualized dividend rate of $1.36 per share. Based on the closing stock price on June 16, 2011, of $56.60 per share, the Company had a market capitalization of approximately $1.7 billion and the indicated dividend yield was 2.40%.
IBERIABANK Corporation operates as the holding company for IBERIABANK that offers commercial and retail banking products and services in the United States. The company’s deposit products primarily include NOW accounts, savings and money market accounts, and certificate of deposits.
National Health Partners, Inc. (OTC:NHPR)
The drivers of high healthcare costs are manifold, and include the perverse incentives associated with an insurance-based payment system, low labor-productivity growth in the provision of care, and the closely related issue of a constrained supply of healthcare providers. The expense of treating the uninsured or under-payments from Medicare and Medicaid is shifted onto private healthcare providers, as is the expense of litigating and/or settling malpractice lawsuits.
National Health Partners, Inc. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called "CARExpress." CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna.
National Health Partners, Inc primary target customer group is the 47 million Americans who have no health insurance of any kind. The company's secondary target customer group includes the millions of Americans who lack complete health insurance coverage.
National Health Partners, Inc., a leading provider of discount healthcare membership programs, announced the recent signing of two new significant marketing agreements. These two clients provide very different opportunities and continue to expand the reach of CARExpress into new marketplaces.
By launching their own unique internet marketing program, the first group should be able to provide a widespread push into the on-line market to produce an excellent volume of new CARExpress sales into the pipeline. In addition, the second group offers a reach into the wholesale marketplace where CARExpress will be wrapped into other programs to enhance the value of the overall package to the consumer. They would consider this non-traditional business and a great opportunity to expand their reach as well as recognition of the CARExpress program nationwide.
The company plans to announce the rollout of these new marketing campaigns as well as several others over the next few weeks.
For more information about National Health Partners, Inc. visit its website at www.nationalhealthpartners.com
Royal Gold, Inc. (NASDAQ:RGLD) announced the expansion of their Board of Directors from seven to eight members, and the election of Gordon Bogden to fill the newly created position. Mr. Bogden has over 30 years experience as a senior executive, investment banker and geoscientist to the mining industry. He has worked with some of the largest mining companies on mergers, acquisitions and restructurings, and raising capital in the international debt and equity markets. Mr. Bogden is Co-Founder, President and Managing Partner of Gryphon Partners in Canada, an independent investment bank with offices in Canada and Australia that provides corporate advisory services to mining companies on strategy and mergers and acquisitions. He is also currently Chairman of Volta Resources Inc, and a director of Aeroquest International Limited and Comino Resources Corp.
Royal Gold, Inc., together with its subsidiaries, acquires and operates precious metals royalties. The company owns royalty interests in various production, development, evaluation, and exploration stage projects, which explore for gold, silver, copper, lead, and zinc metals. The Company's website is located at www.royalgold.com.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM). Crown Equity Holdings Inc. (OTCPK:CRWE) has received 3,000,000 shares of (144) restricted common stock from the company and 3,000,000 shares of free trading shares from a third party (PIERRE BESUCHET) for six months of advertisement services for National Health Partners Inc. (OTC:NHPR).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup